Press "Enter" to skip to content

New patent for Melinta Theraps drug BAXDELA


Annual Drug Patent Expirations for BAXDELA
Annual Drug Patent Expirations for BAXDELA

Baxdela is a drug marketed by Melinta Theraps Inc
and is included in two NDAs. It is available from one supplier. There are eight patents protecting this drug.

This drug has twenty-nine patent family members in fifteen countries.

The generic ingredient in BAXDELA is delafloxacin meglumine. One supplier is listed for this compound. Additional details are available on the delafloxacin meglumine profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
or visit

Do NOT follow this link or you will be banned from the site!